FAQ/Help |
Calendar |
Search |
Today's Posts |
|
Parkinson's Disease Clinical Trials For posting and discussion of clinical trials related to Parkinson's Disease, and for the Parkinson Pipeline Project. All are welcome. |
Reply |
|
Thread Tools | Display Modes |
09-21-2010, 08:27 AM | #1 | ||
|
|||
In Remembrance
|
Chelsea Therapeutics Presents Data at 14th International Congress on Parkinson's Disease and Movement Disorders
Read more: http://www.drugs.com/clinical_trials...#ixzz10Ac6FQS2 -- Clinical Review Highlights Neuroprotective Potential of Norepinephrine in Parkinson's Disease -- Northera, an Orally Available Norepinephrine Pro-drug, Significantly Improves Symptoms of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease -- Over 25 Years of Research Support Cardiovascular Safety of Northera in Patient Population Characterized by Advanced Age and Significant Co-Morbidities Read more: http://www.drugs.com/clinical_trials...#ixzz10AZyEMQd Chelsea Therapeutics Soars As Parkinson's Study Successful must subscribe http://online.wsj.com/article/BT-CO-...20-703879.html
__________________
paula "Time is not neutral for those who have pd or for those who will get it." |
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
interesting CME article - NEUROPROTECTIVE STRATEGIES | Parkinson's Disease | |||
Another Neuroprotective Possibility from the Kitchen | Parkinson's Disease | |||
Loss Of Two Types Of Neurons Triggers Parkinson's (norepinephrine and dopamine) | Parkinson's Disease | |||
Is this the first neuroprotective drug ... | Parkinson's Disease | |||
Neuroprotective therapy in Parkinson disease | Parkinson's Disease |